Epigral Ltd.
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar … Read more
Market Cap & Net Worth: Epigral Ltd. (EPIGRAL)
Epigral Ltd. (NSE:EPIGRAL) has a market capitalization of $425.09 Million (₹36.81 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #17061 globally and #773 in its home market, demonstrating a -1.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epigral Ltd.'s stock price ₹853.35 by its total outstanding shares 43141338 (43.14 Million).
Epigral Ltd. Market Cap History: 2023 to 2026
Epigral Ltd.'s market capitalization history from 2023 to 2026. Data shows change from $485.05 Million to $425.09 Million (-6.13% CAGR).
Index Memberships
Epigral Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.73 Billion | 0.02% | #364 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.32 Trillion | 0.01% | #572 of 750 |
Weight: Epigral Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Epigral Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Epigral Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Epigral Ltd.'s market cap is 0.02 times its annual revenue
8.83x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.17x
Epigral Ltd.'s market cap is 0.17 times its annual earnings
4.10x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $485.05 Million | $21.69 Billion | $3.53 Billion | 0.02x | 0.14x |
| 2024 | $944.58 Million | $18.94 Billion | $1.96 Billion | 0.05x | 0.48x |
| 2025 | $607.79 Million | $25.50 Billion | $3.58 Billion | 0.02x | 0.17x |
Competitor Companies of EPIGRAL by Market Capitalization
Companies near Epigral Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Epigral Ltd. by market ranking:
- Linde PLC (XETRA:LIN): Ranked #84 globally with a market cap of $187.60 Billion USD ( €182.76 Billion EUR).
- BASF SE NA O.N. (OTCQX:BFFAF): Ranked #461 globally with a market cap of $47.09 Billion USD.
- Shin-Etsu Chemical Co. Ltd (PINK:SHECF): Ranked #470 globally with a market cap of $46.17 Billion USD.
- A. Schulman Inc (PINK:SLMNP): Ranked #826 globally with a market cap of $23.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Linde PLC | XETRA:LIN | $187.60 Billion | €429.40 |
| #461 | BASF SE NA O.N. | OTCQX:BFFAF | $47.09 Billion | $53.46 |
| #470 | Shin-Etsu Chemical Co. Ltd | PINK:SHECF | $46.17 Billion | $24.66 |
| #826 | A. Schulman Inc | PINK:SLMNP | $23.93 Billion | $901.00 |
Epigral Ltd. Historical Marketcap From 2023 to 2026
Between 2023 and today, Epigral Ltd.'s market cap moved from $485.05 Million to $ 425.09 Million, with a yearly change of -6.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹425.09 Million | -30.06% |
| 2025 | ₹607.79 Million | -35.66% |
| 2024 | ₹944.58 Million | +94.74% |
| 2023 | ₹485.05 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Epigral Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $425.09 Million USD |
| MoneyControl | $425.09 Million USD |
| MarketWatch | $425.09 Million USD |
| marketcap.company | $425.09 Million USD |
| Reuters | $425.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.